Table 4.
N(%) | OR | 95% CI | χ2 | P | |
---|---|---|---|---|---|
Females | 24 (22.2) | 2.4 | 0.5-10.6 | 1.3 | 0.244 |
North-Center | 20 (23.8) | 2.0 | 0.7-6.0 | 1.7 | 0.194 |
Age 18-24 | 2 (10.0) | 1.01 | 0.95-1.1 | 0.1 | 0.6 |
Age 25-64 | 19 (17.4) | 0.5 | 0.9-1.3 | 1.1 | 0.291 |
Age > 64 | 6 (33.3) | 2.3 | 0.6-8.8 | 1.5 | 0.214 |
*MDQ > 7 | 7.5 (41.7) | 3.6 | 1.1-40.5 | 4.8 | 0.028 |
*Comorbidity PD | 9.6 (53.3) | 17.2 | 6-49.2 | 27.2 | 0.0001 |
*Comorbidity DOC | 2.8 (40.0) | 2.9 | 0.5-1.3 | 0.8 | 0.369 |
*Comorbidity GAD | 6.9 (43.1) | 4.2 | 1.2-13.8 | 5.6 | 0.018 |
*Standardized by age, sex and residence (N/S); °Vs overall sample receiving ADs (with exclusion of DE point prevalence)°°The Odds Ratio is calculated vs all other age frequencies